LONDON, March 30 /PRNewswire/ -- The higher incidence of chronic illnesses in Europe and the consequent increase of patient population in intensive care units has amplified the need for equipment that measure vital signs such as blood pressure during surgeries. This rise in the number of people requiring critical care has escalated the demand for catheters and transducers.
New analysis from Frost & Sullivan (http://www.patientmonitoring.frost.com), European Market for Invasive Pressure Monitoring and Hemodynamic Monitoring, finds that market earned revenues of $336.4 million in 2007 and is estimated to touch $520.6 million by 2014. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: central venous catheters, pulmonary artery catheters and disposable pressure transducers.
If you are interested in a virtual brochure, which provides a brief synopsis of the research and a table of contents, then send an e-mail to Katja Feick, Corporate Communications, at email@example.com, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country. Upon receipt of the above information, a brochure will be sent to you by e-mail.
"Hospitals do not consider non-invasive method of blood pressure monitoring accurate; they prefer continuous invasive blood pressure monitoring that provides quick and correct readings," says Frost & Sullivan Research Analyst Akanksha Joshi. "Therefore, there is significant demand for disposable pressure transducers and catheters that provide invasive blood pressure monitoring."
With both hospitals and patients gravitating towards non-invasive methods due to their benefits of lower costs and reducing the trauma faced by patients, smaller incisions, shorter hospital stay and faster recovery, medical device manufacturers have to innovate constantly to keep pace with these developments in surgical techniques.
Manufacturers must offer novel products that enhance patient comfort and safety to attract more users. For instance, the use of antibiotic coating in central venous catheters has greatly reduced the risk of infection from the catheter. Such instruments will be especially pertinent in the current market scenario, since shrinking hospital budgets and low reimbursements levels are making a case for highly technically innovative equipment that will reduce the incision size and the duration of hospital care.
Budgetary constraints are also the reason that many hospitals favour bulk buying of catheters and transducers. This puts manufacturers under pressure to lower their prices, and thereby, their profit margins, they are hence, resorting to outsourcing production to lower manufacturing costs. Market participants can also garner higher revenues, retain existing clients and expand their customer base by offering value-added services.
"Manufacturers and suppliers can train their technicians and servicing staff in collaboration with medical institutes to improve the knowledge base of service staff and subsequently, productivity," notes Joshi. "Continuous interactions between the medical staff and manufacturers through their sales and marketing personnel will also aid the better understanding of the products."
European Market for Invasive Pressure Monitoring and Hemodynamic Monitoring is part of the Patient Monitoring Growth Partnership Service program, which also includes research in the following markets: European non - invasive blood pressure monitoring market, European remote patient monitoring market and European diagnostic cardiovascular monitoring equipment market. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.
GIL 2009: Europe
Frost & Sullivan has expanded its flagship Global Congress on Corporate Growth - GIL Global - into several major cities around the world including London. For the first time ever in Europe, Frost & Sullivan will be hosting the Growth, Innovation and Leadership Congress 'GIL 2009: Europe' on 19-20 May, at the Sofitel St James in London. GIL Global is the industry's only event designed to support senior executives in their efforts to achieve sustainable, top-line growth. To register, obtain a programme agenda, explore sponsorship opportunities, or attend as a member of the media for GIL 2009: Europe, please contact Katja Feick, Corporate Communications Europe, at firstname.lastname@example.org. One-on-One interviews with Frost & Sullivan senior growth consultants are also being scheduled. For more information you can also visit http://www.frost.com/gilglobal
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.
European Market for Invasive Pressure Monitoring and Hemodynamic Monitoring
Contact: Katja Feick Corporate Communications - Europe P: +49 (0) 69 7703343 E: email@example.com http://www.frost.com
|SOURCE Frost & Sullivan|
Copyright©2009 PR Newswire.
All rights reserved